2025-05-19

King-Friend will meet you in CPHI Frankfurt!

Return

Previous NKF's Cyanocobalamin Injection gets FDA approval for marketing Next Paclitaxel For Injection (Albumin Bound) approved by US FDA

Relevant recommendations

2025-10-21

NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!
2025-10-17

NKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
2025-08-04

NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
2025-07-21

NKF makes its debut at CPHI Southeast Asia
2025-07-14

King-Friend will meet you in CPHI Malaysia！

Stock price

9.620

-0.020000000000001

©2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd苏ICP备13012010号